Sara W. Quist - Publications

Cost-minimisation analysis of anti-VEGF therapies in neovascular age-related macular degeneration and diabetic macular oedema in Switzerland.

Journal: Journal of medical economics

Published: July 22, 2025

Correction: Cost‑effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands.

Journal: Cardiovascular diabetology

Published: May 15, 2025

Clinical outcomes of chikungunya across age groups: A systematic review.

Journal: PLoS neglected tropical diseases

Published: April 25, 2025

Anti-VEGFs for Diabetic Macular Oedema: Analysis of Efficacy, Safety, and Cost of More Durable Therapies from a Dutch Societal Perspective.

Journal: Advances in therapy

Published: April 02, 2025

Cost-effectiveness of treatment with finerenone in mild to advanced stage chronic kidney disease patients with type 2 diabetes from a societal perspective.

Journal: BMJ public health

Published: April 08, 2024

A cost-minimization analysis of anti-VEGFs for the treatment of neovascular age-related macular degeneration in the Netherlands.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: March 22, 2024

Cost-effectiveness of hydroxychloroquine retinopathy screening: the current guideline versus no screening and reduced regimens.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: December 05, 2023

Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands.

Journal: Cardiovascular diabetology

Published: August 18, 2023

Costs of radium-223 and the pharmacy preparation 177Lu-PSMA-I&T for metastatic castration-resistant prostate cancer in Dutch hospitals.

Journal: Journal of medical economics

Published: March 11, 2023

Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: August 19, 2021

Cost-minimisation analysis of a treat-and-extend regimen with anti-VEGFs in patients with neovascular age-related macular degeneration.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: May 06, 2021